Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,170 | 29 | 77.9% |
| Travel and Lodging | $6,742 | 41 | 10.9% |
| Food and Beverage | $4,624 | 198 | 7.5% |
| Consulting Fee | $2,220 | 3 | 3.6% |
| Education | $97.37 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $21,252 | 44 | $0 (2023) |
| Shire North American Group Inc | $19,211 | 65 | $0 (2019) |
| Allergan, Inc. | $19,094 | 62 | $0 (2021) |
| Alkermes, Inc. | $608.84 | 18 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $429.91 | 27 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $367.29 | 26 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $222.50 | 7 | $0 (2020) |
| Tris Pharma Inc | $206.41 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $170.68 | 6 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $125.35 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $171.74 | 2 | Tris Pharma Inc ($171.74) |
| 2023 | $7,275 | 20 | ABBVIE INC. ($7,275) |
| 2022 | $5,757 | 11 | ABBVIE INC. ($5,757) |
| 2021 | $10,650 | 17 | AbbVie Inc. ($8,220) |
| 2020 | $16,313 | 36 | Allergan, Inc. ($16,200) |
| 2019 | $660.78 | 40 | Allergan Inc. ($137.32) |
| 2018 | $848.41 | 42 | Shire North American Group Inc ($174.74) |
| 2017 | $20,177 | 105 | Shire North American Group Inc ($19,016) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Tris Pharma Inc | Onyda XR (Drug) | Food and Beverage | In-kind items and services | $73.45 | General |
| Category: ADHD | ||||||
| 07/10/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $98.29 | General |
| Category: ADHD | ||||||
| 08/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $175.54 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $103.46 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $55.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $631.62 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $477.20 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $182.49 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $62.88 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $47.21 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $45.70 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $111.07 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $142.74 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 40 | $2,662 | $1,402 |
| 2022 | 1 | 22 | 45 | $2,994 | $1,337 |
| 2021 | 2 | 41 | 88 | $6,723 | $4,119 |
| 2020 | 1 | 45 | 83 | $5,575 | $2,142 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 40 | $2,662 | $1,402 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 45 | $2,994 | $1,337 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 62 | $4,125 | $2,220 | 53.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 26 | $2,597 | $1,899 | 73.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 83 | $5,575 | $2,142 | 38.4% |
About Dr. Michael Hill, MD
Dr. Michael Hill, MD is a Psychiatry healthcare provider based in Lebanon, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174568349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hill, MD has received a total of $61,853 in payments from pharmaceutical and medical device companies, with $171.74 received in 2024. These payments were reported across 273 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($48,170).
As a Medicare-enrolled provider, Hill has provided services to 121 Medicare beneficiaries, totaling 256 services with total Medicare billing of $9,000. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Lebanon, TN
- Active Since 06/19/2006
- Last Updated 12/09/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1174568349
Products in Payments
- VRAYLAR (Drug) $40,346
- MYDAYIS (Drug) $19,119
- LATUDA (Drug) $367.29
- REXULTI (Drug) $253.48
- ABILIFY MAINTENA (Drug) $234.29
- INGREZZA (Drug) $222.50
- Aristada 441 mg (Drug) $175.84
- AUSTEDO (Drug) $170.68
- ARISTADA (Drug) $133.00
- Dyanavel XR (Drug) $132.96
- VYVANSE (Drug) $92.42
- INVEGA SUSTENNA (Drug) $86.59
- Onyda XR (Drug) $73.45
- Fanapt (Drug) $66.06
- Adzenys XR-ODT (Drug) $40.77
- SPRAVATO (Drug) $38.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lebanon
Dr. Robert Cotes, Md, MD
Psychiatry — Payments: $59,911
Anne Dall
Psychiatry — Payments: $9,537
Nhien Nguyen, Md, MD
Psychiatry — Payments: $7,810
Dr. Paul Holtzheimer, Md, MD
Psychiatry — Payments: $7,352
Dr. Kathleen Elnaggar, Md, MD
Psychiatry — Payments: $5,489
Dr. Karen Medzoyan, Md, MD
Psychiatry — Payments: $4,266